AMPH logo

AMPH EBITDA

annual EBITDA:

$220.11M-$20.19M(-8.40%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AMPH annual EBITDA is $220.11 million, with the most recent change of -$20.19 million (-8.40%) on December 31, 2024.
  • During the last 3 years, AMPH annual EBITDA has risen by +$108.55 million (+97.30%).
  • AMPH annual EBITDA is now -8.40% below its all-time high of $240.29 million, reached on December 31, 2023.

Performance

AMPH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

quarterly EBITDA:

$52.35M-$12.70M(-19.52%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AMPH quarterly EBITDA is $52.35 million, with the most recent change of -$12.70 million (-19.52%) on March 31, 2025.
  • Over the past year, AMPH quarterly EBITDA has dropped by -$18.09 million (-25.68%).
  • AMPH quarterly EBITDA is now -42.41% below its all-time high of $90.91 million, reached on September 30, 2023.

Performance

AMPH quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

TTM EBITDA:

$259.22M-$18.09M(-6.53%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AMPH TTM EBITDA is $259.22 million, with the most recent change of -$18.09 million (-6.53%) on March 31, 2025.
  • Over the past year, AMPH TTM EBITDA has dropped by -$10.16 million (-3.77%).
  • AMPH TTM EBITDA is now -13.29% below its all-time high of $298.95 million, reached on June 30, 2024.

Performance

AMPH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMPHincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

AMPH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.4%-25.7%-3.8%
3 y3 years+97.3%+44.7%+91.0%
5 y5 years+170.2%+347.4%+767.6%

AMPH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.4%+97.3%-42.4%+72.3%-13.3%+98.3%
5 y5-year-8.4%+629.0%-42.4%>+9999.0%-13.3%+767.6%
alltimeall time-8.4%+1192.2%-42.4%+886.1%-13.3%+1755.8%

AMPH EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$52.35M(-19.5%)
$259.22M(-6.5%)
Dec 2024
$220.11M(-8.4%)
$65.05M(-5.5%)
$277.31M(+0.2%)
Sep 2024
-
$68.81M(-5.7%)
$276.85M(-7.4%)
Jun 2024
-
$73.00M(+3.6%)
$298.95M(+11.0%)
Mar 2024
-
$70.45M(+9.1%)
$269.38M(+12.1%)
Dec 2023
$240.29M(+64.4%)
$64.59M(-29.0%)
$240.29M(+6.9%)
Sep 2023
-
$90.91M(+109.3%)
$224.82M(+36.8%)
Jun 2023
-
$43.43M(+5.0%)
$164.40M(+8.6%)
Mar 2023
-
$41.36M(-15.8%)
$151.34M(+3.5%)
Dec 2022
$146.16M(+31.0%)
$49.11M(+61.1%)
$146.16M(+11.8%)
Sep 2022
-
$30.49M(+0.4%)
$130.71M(-9.8%)
Jun 2022
-
$30.38M(-16.0%)
$144.91M(+6.8%)
Mar 2022
-
$36.18M(+7.5%)
$135.70M(+21.6%)
Dec 2021
$111.56M(+269.5%)
$33.66M(-24.7%)
$111.56M(+43.0%)
Sep 2021
-
$44.68M(+111.1%)
$78.01M(+65.1%)
Jun 2021
-
$21.17M(+75.8%)
$47.25M(+54.8%)
Mar 2021
-
$12.04M(>+9900.0%)
$30.53M(+1.1%)
Dec 2020
$30.19M(-62.9%)
$116.00K(-99.2%)
$30.19M(-18.3%)
Sep 2020
-
$13.92M(+212.9%)
$36.93M(+23.6%)
Jun 2020
-
$4.45M(-62.0%)
$29.88M(-67.4%)
Mar 2020
-
$11.70M(+70.6%)
$91.64M(+12.5%)
Dec 2019
$81.47M(+1092.3%)
$6.86M(-0.2%)
$81.47M(+2.4%)
Sep 2019
-
$6.87M(-89.6%)
$79.58M(-0.0%)
Jun 2019
-
$66.21M(+4230.4%)
$79.58M(+491.9%)
Mar 2019
-
$1.53M(-69.2%)
$13.44M(+96.8%)
DateAnnualQuarterlyTTM
Dec 2018
$6.83M(-61.8%)
$4.97M(-27.7%)
$6.83M(+40.7%)
Sep 2018
-
$6.87M(+9060.0%)
$4.86M(+1627.8%)
Jun 2018
-
$75.00K(-101.5%)
$281.00K(-96.2%)
Mar 2018
-
-$5.08M(-269.9%)
$7.46M(-58.7%)
Dec 2017
$17.89M(-41.0%)
$2.99M(+30.3%)
$18.05M(+28.1%)
Sep 2017
-
$2.30M(-68.3%)
$14.10M(-35.3%)
Jun 2017
-
$7.25M(+31.4%)
$21.80M(-22.8%)
Mar 2017
-
$5.52M(-670.4%)
$28.22M(-7.0%)
Dec 2016
$30.33M(+682.8%)
-$967.00K(-109.7%)
$30.33M(-32.8%)
Sep 2016
-
$10.00M(-26.9%)
$45.12M(+31.0%)
Jun 2016
-
$13.67M(+79.3%)
$34.44M(+144.1%)
Mar 2016
-
$7.63M(-44.8%)
$14.11M(+264.1%)
Dec 2015
$3.88M(-225.4%)
$13.82M(-2129.4%)
$3.88M(-130.9%)
Sep 2015
-
-$681.00K(-89.8%)
-$12.54M(-19.9%)
Jun 2015
-
-$6.66M(+155.8%)
-$15.65M(+129.6%)
Mar 2015
-
-$2.60M(+0.5%)
-$6.82M(+120.6%)
Dec 2014
-$3.09M(-109.9%)
-$2.59M(-31.8%)
-$3.09M(-151.8%)
Sep 2014
-
-$3.80M(-274.6%)
$5.96M(-56.0%)
Jun 2014
-
$2.18M(+93.7%)
$13.56M(-49.5%)
Mar 2014
-
$1.12M(-82.6%)
$26.85M(-14.1%)
Dec 2013
$31.26M(-18.1%)
$6.46M(+70.1%)
$31.26M(+26.1%)
Sep 2013
-
$3.80M(-75.4%)
$24.80M(+18.1%)
Jun 2013
-
$15.46M(+179.4%)
$21.00M(+279.4%)
Mar 2013
-
$5.54M
$5.54M
Dec 2012
$38.16M(-289.3%)
-
-
Dec 2011
-$20.15M
-
-

FAQ

  • What is Amphastar Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual EBITDA year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Amphastar Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals TTM EBITDA year-on-year change?

What is Amphastar Pharmaceuticals annual EBITDA?

The current annual EBITDA of AMPH is $220.11M

What is the all time high annual EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual EBITDA is $240.29M

What is Amphastar Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, AMPH annual EBITDA has changed by -$20.19M (-8.40%)

What is Amphastar Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of AMPH is $52.35M

What is the all time high quarterly EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly EBITDA is $90.91M

What is Amphastar Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, AMPH quarterly EBITDA has changed by -$18.09M (-25.68%)

What is Amphastar Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of AMPH is $259.22M

What is the all time high TTM EBITDA for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high TTM EBITDA is $298.95M

What is Amphastar Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, AMPH TTM EBITDA has changed by -$10.16M (-3.77%)
On this page